COMPOUND, COMPOSITION, AND METHODS FOR TREATING, PREVENTING, REDUCING, OR DELAYING ONSET OF OSTEOSARCOMA LUNG METASTASIS IN A SUBJECT

Described herein is a method for treating, preventing, reducing, or delaying onset of, osteosarcoma lung metastasis in a subject, comprising: administering a therapeutically or prophylactically effective amount of a PPARγ agonist, an anti- inflammatory agent, or a neutrophil depleting agent, to a su...

Full description

Saved in:
Bibliographic Details
Main Authors WIERENGA, Lauren A, SENGER, Donna L, ROBBINS, Stephen M
Format Patent
LanguageEnglish
French
Published 26.07.2018
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described herein is a method for treating, preventing, reducing, or delaying onset of, osteosarcoma lung metastasis in a subject, comprising: administering a therapeutically or prophylactically effective amount of a PPARγ agonist, an anti- inflammatory agent, or a neutrophil depleting agent, to a subject having or suspected of having osteosarcoma. L'invention concerne une méthode pour traiter, prévenir, réduire ou retarder l'apparition d'une métastase pulmonaire d'ostéosarcome chez un patient, comprenant l'administration d'une quantité thérapeutiquement ou prophylactique efficace d'un agoniste de PPARγ, d'un agent anti-inflammatoire, ou d'un agent de déplétion des neutrophiles, à un patient atteint, ou suspecté d'être atteint, d'un ostéosarcome.
Bibliography:Application Number: WO2018CA50040